Search

everythinglearnresearchcommunity

for

Search:↓

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Testosterone may slow down wound healing and increase inflammation.

Hydrogels could lead to better treatments for wound healing without scars.

Disrupting Acvr1b in mice causes severe hair loss and thicker skin.

Some natural compounds can protect fish ear cells from damage by certain antibiotics without affecting the antibiotics' ability to fight infections.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Fat cells are important for tissue repair and stem cell support in various body parts.

Using a gene therapy with the Sonic Hedgehog gene helps mice regrow hair faster after losing it from chemotherapy.

Fibroblasts, cells usually linked to tissue repair, also help regenerate various organs and their ability decreases with age. Turning adult fibroblasts back to a younger state could be a new treatment approach.

Fibromodulin treatment helps reduce scarring and improves wound healing by making it more like fetal healing.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

A protein called PLC2 is important for the growth and development of plant roots influenced by auxin.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Mathematical modeling can improve regenerative medicine by predicting biological processes and optimizing therapy development.

Multimodal minoxidil microemulsion is more effective in treating hair loss than minoxidil alone.

Tissue stiffness affects hair follicle regeneration, and Twist1 is a key regulator.

Bimatoprost can cause longer, thicker, darker eyelashes and eyebrows.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Synthetic melanin applied to skin speeds up wound healing.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Quercetin-loaded nanoparticles can penetrate skin, minimize hair loss, and promote hair regrowth, showing slightly better results than a marketed product.

Long-term use of dutasteride can cause permanent erectile dysfunction in rats.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Hair loss in certain young mice is linked to a specific gene and can be caused by lack of iron.

Ranitidine and finasteride lower TMAO levels, reducing heart and kidney damage by changing gut bacteria.

Morroniside has many health benefits, including protection against diabetes complications, bone and brain diseases, heart and skin issues, and it supports hair growth and reduces inflammation.